Home / Market News / $RGEN
fiscal.ai Corporate Catalyst Impact 60/100 ● positive

RBC Capital Markets Raises Price Target on Repligen Corporation

Oct 28, 2026, 6:07 PM UTC · Primary ticker $RGEN

RBC Capital Markets has increased its price target for Repligen Corporation from $185 to $200, while reiterating an 'Outperform' rating. This adjustment signals a more optimistic view from the analyst on the company's future performance and market valuation.

RBC Capital Markets has raised its price target on Repligen Corporation (RGEN) from $185 to $200, maintaining an 'Outperform' rating. This analyst upgrade reflects a more positive outlook on Repligen's fundamentals and growth prospects, suggesting that RBC believes the stock has further upside potential. For traders, this could lead to short-term positive sentiment and potentially increased buying interest in RGEN shares. The long-term implication is a reinforced bullish view from a prominent financial institution, which could attract more institutional investors. The key opportunity for traders is to capitalize on this renewed analyst confidence, though the impact might be moderate as it's an adjustment rather than a new rating.

$RGEN positive Price target increase, Outperform rating maintained
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.